Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELUXADOLINE vs EMAPALUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELUXADOLINE vs EMAPALUMAB: Safety Overview

Metric ELUXADOLINE EMAPALUMAB
Total FAERS Reports 2,353 173
Deaths Reported 37 63
Death Rate 1.6% 36.4%
Hospitalizations 413 84
Average Patient Age 57.4 yrs 17.1 yrs
% Female Patients 77.7% 48.7%
FDA Approval Date Mar 14, 2025 N/A
Manufacturer Allergan, Inc. Swedish Orphan Biovitrum AB (publ)
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A